Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 28 January 2027
- Last conf. stmt
- 14 January 2026
Cambridge Nucleomics Ltd
- Incorporated
- 15 January 2021 (5 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Hendrik Friedrich Peter Runge
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- Meditrina BuildingBabraham Research CampusCambridgeCB22 3AT
Officers
Current officers not loaded yet. See them on Companies House
Officer details are public data from the Companies House register.
Officer history (1 former)
17 July 2026
3 March 2025
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Hendrik Friedrich Peter Runge
Individual · Notified 28 October 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
German
Born February 1991 (35)
Former controllers (2)
3 March 2025
Ceased Ulrich Felix Keyser — Owns 25–50% of shares
1 August 2022
Ceased Max Zhu — Owns 25–50% of shares
Financials
Balance sheet as at 30 June 2025 · total exemption full accounts
- Net Assets
- £399,086
- Cash
- £527,579
- Employees
- 2
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current Assets | £548,876 | £35,548 | £54,626 | |
| Debtors | £21,297 | £25,161 | £13,049 | |
| Cash | £527,579 | £10,387 | £41,577 | £4,608 |
| Creditors (< 1 year) | £3,021 | |||
| Creditors (> 1 year) | £128,362 | £128,362 | £128,362 | |
| Net Current Assets | £527,448 | £21,057 | £50,425 | |
| Net Assets | £399,086 | (£107,305) | (£77,937) | £1,587 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 August 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →